Oncocytic carcinoma of the salivary gland with thymoma: A case report and review of the literature

  • Authors:
    • Yongcheng Cao
    • Ming Zhu
    • Ruiqi Mao
    • Ruixue Cao
    • Guoli Yu
    • Aijun Niu
  • View Affiliations

  • Published online on: November 19, 2014     https://doi.org/10.3892/ol.2014.2707
  • Pages: 681-684
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Oncocytic carcinoma (OC) arising in the salivary gland is a very rare tumor with only 32 previously reported cases. In this report, we describe a novel case of oncocytic carcinoma with associated thymoma, which arose in the left parotid gland of a 66‑year‑old male with a history of a painless left parotid mass for 1 year. Oncocytes are large, polygonal cells that are characterized by marked cellular atypia, frequent mitoses, wide eosinophilic granular cytoplasm, a central nucleus and a prominent nucleolus. The follow‑up data showed no evidence of recurrence and the patient is in a good health 20 months after the surgery. In the current case, the patient had not only OC but also thymoma, which is exceedingly rare and may represent the first documented case in the literature.

Introduction

Oncocytic carcinomas (OCs) are very rare neoplasms that have been reported to occur in the nasal and thoracic cavities, ovary, kidney, thyroid gland, salivary gland, breast and parathyroid (1,2). These tumors represent 11% of all oncocytic salivary gland neoplasms, 0.5% of all epithelial salivary gland malignancies and 0.18% of all epithelial salivary gland tumors (1). Bauer and Bauer (3) reported the first case in 1953, and, in total, only 31 cases have been reported in English-language literature (422).

Oncocytes are typically large epithelial cells with a low nuclear-to-cytoplasmic ratio, a centrally situated round nucleus with a prominent nucleolus and an abundant bright eosinophilic granular cytoplasm that is ultrastructurally characterized by numerous mitochondria (14). Thymic epithelial tumors include thymomas and thymic carcinomas. Although occurence is rare (accounting for 0.2–1.5% of all malignancies) (23), they present the most common tumor of the anterior mediastinum (24). Thymomas are neoplasms arising from or exhibiting differentiation towards thymic epithelial cells. Thymomas are classified into two major types depending on whether the neoplastic epithelial cells have an oval shape and are uniformly bland (type A thymoma) or whether the cells have a predominantly round or polygonal appearance (type B thymoma). Thymomas which exhibit type A and B-like features are classified as type AB (25). In this case report, the patient not only had OC but also thymoma. To the best of our knowledge, this is the first reported case of an OC patient exhibiting type AB thyoma. Written informed consent was obtained from the patient.

Case report

Case presentation

A 66-year-old male was admitted to the General Hospital of Jinan Military Command (Jinan, China) with a 1-year history of a painless left parotid mass that was gradually increasing in size. Physical examination revealed a fixed, hard, 3×2-cm mass with a smooth surface in the left parotid region. There was no palpable lymph node in the parotid gland or on the left side of the neck. Systemic physical and laboratory examinations revealed no abnormalities. Echography of the neck revealed an area of mixed echoes in the left parotid gland. Computed tomography (CT) demonstrated a 3×2-cm solid lesion in the left parotid gland and a 4.5×4.5-cm mass in the region of thymus. Radical resection of the parotid tumor and thoracotomy resection of the thymic tumor were performed.

Tissue staining

The specimen was fixed in neutral buffered formalin and routinely processed with tissue sections embedded in paraffin. The sections were cut into 4-μm slices and stained with hematoxylin and eosin (H&E) for conventional evaluation. In addition to H&E, the following immunostains and special tissue stains were used: Cytokeratin (CK, AE1/AE3; Dako, Carpinteria, CA, USA), carcinoembryonic antigen (CEA; Zymed, San Francisco, CA, USA), p53 (Dako), S-100 (4c4.9; Zymed), Ki-67 (Dako) and phosphotungstic acid-hematoxylin (PTAH; Shanghai Lanji Science and Technology Co., Ltd., Shanghai, China).

Macroscopic findings

The parotid tumor consisted of unencapsulated, irregular, cord-like, tan to gray masses. The cut surface was light brown, solid, and non-homogeneous with cystic degeneration, necrosis or hemorrhage (Fig. 1). The tumor of the thymus was encapsulated and its cut surface was solid and light brown (Fig. 2).

Microscopic findings and immunohistochemistry

The parotid tumor had replaced a large area of the parotid gland, but perineural invasion and vascular invasion were not found. Neoplastic elements were large, round or polyhedral cells and were arranged in solid sheets, islands and cords. The cytoplasm was abundant, eosinophilic and finely granular. The nuclei were large and centrally or peripherally located, and the nucleoli were distinct and large (Fig. 3). PTAH staining distinctly illustrated positive, small, dark-blue cytoplasmic granules, which represented mitochondria (Fig. 4). Tumor cells were positive for CK, CEA, S-100 and p53 by immunohistochemistry. Additionally, PTAH staining illustrated positive dark-blue cytoplasmic granules. The tumor of the thymus consisted of a homogeneous population of neoplastic epithelial cells that were spindle- or oval-shaped and lacked nuclear atypia, admixed with foci rich in lymphocytes. The segregation of the two patterns was sharp and distinct (Fig. 5).

Discussion

Oncocytes are large, granular, eosinophilic epithelial cells that are primarily found in glandular tissue, including that of the salivary glands and thyroid. In 1931, the pathologist Hamperl (26) used the term ‘oncocyte’ for this distinctive and typical cell type, which was taken from the Greek word ‘onkousthai’ (27). Normal oncocytes are observed in the salivary glands of aged patients and are considered to represent an age-related metaplasia or degenerative process (28). In salivary gland ductal epithelium, the appearance of oncocytes (oncocytic metaplasia) is rare prior to the age of 50; however, it is nearly universal beyond age 70. In 1989, Linnane et al (29) hypothesized that aging is the accumulation of mtDNA errors that lead to mitochondrial ‘respiratory failure’ and multisystem degeneration.

According to the World Health Organization histologic classification of salivary gland tumors (30), parotid oncocytic neoplasms are divided into three categories, including oncocytosis, oncocytoma and OC. OC has been given several names in the past, including oncocytic adenocarcinoma, malignant oncycytoma and malignant oxyphilic adenoma. Sugimoto et al (31) reported that OC commonly presents as a parotid mass with pain and facial nerve paralysis, and that such symptoms were observed in one of three patients with OC. However, the primary symptom in the patient reported in the current study was a slowly progressive, painless mass. Oncocytic carcinomas appear to arise from benign oncocytomas; however, they may arise de novo (30). In the current case, the malignant nature of the neoplasm was evidenced by the regional and distant lymph node metastases. No perineural invasion or infiltration of subcutaneous tissue was observed. Criteria for the diagnosis of oncocytic carcinoma of the salivary gland include: i) distant metastasis; ii) local lymph node metastasis; iii) perineural, vascular, or lymphatic invasion; and iv) frequent mitoses and cellular pleomorphism with extensive invasion and destruction of adjacent structures (32).

It has been reported that OC occurs predominately in the parotid gland of older adults with a mean age of occurrence of 62.5 years, and two-thirds of all cases occurring in males (30). We reviewed previous literature from the past 15 years (Table I) and found only 32 cases of parotid OC. In the current case, the patient age (historically ranging from 41 to 86 years with a median age of 62.5 years) and tumor location (historically 62.5% in the parotid gland) were in agreement with those of the previous reports.

Table I

Reports of oncocytic carcinomas in the salivary gland.

Table I

Reports of oncocytic carcinomas in the salivary gland.

Author (ref)AgeSexSiteSize (cm)Rec.LM
Guclu (4)65FP3YN
Mizutari (5)55MSm3NN
Kimura (6)61MP4NY
Wischerath (7)59MSm2NY
Lombardi (8)45MOthNNN
Sugiyama (9)84MOth4NN
Ardekian (10)64MP8NN
Cinar (11)48FP6NY
Muramatsu (12)82MSm4.5NY
Ozawa (13)58MP3NY
Nakada (14)68MSm3NY
Corbridge (15)57MP4NY
Yang (16)64MSm3.8NY
Wang (17)73MP3NY
Tian (18)66MP3YN
Dong (19)57MSm3NN/A
Zhou (20)60MOth3.5YY
57MP7NY
48MP3NN
59MP8NY
75MP3YY
68MP4YN
41MP3NN
55MP2.5NY
67FP3.5YN
86MP1YN
51FOth4YY
68MP3YN
Lee (21)51MSm3NY
Gallego (22)65MP2.5NY
Present case66MP2.5NY

[i] M, male; F, female; P, parotid; Sm, submaxillary salivary gland; Oth, other salivary gland; LM, lymph node metastasis; Rec., recurrence; N/A, not available; Y, yes; N, no.

Oncocytic carcinoma can be differentiated from benign oncocytoma, since the former includes distant metastases; local lymph node metastases; perineural, intravascular, or lymphatic invasion; and mitoses and cellular polymorphisms with destructive invasion of adjacent structures. Ki-67 immunostaining has been proposed as a tool for distinguishing OC from oncocytomas (33). In a previous study, the frequency of Ki-67 positive cells with nuclear staining was higher in OC compared to oncocytomas (34).

In contrast to oncocytic carcinoma, salivary duct carcinoma forms duct-like spaces with papillary and cribriform growth, and displays comedonecrosis (2). In addition, the presence of numerous mitochondria in the cytoplasm of the oncocytes, as confirmed by ultrastructural examination, is not found in the neoplastic cells of the other malignancies mentioned above, which can also be used for adjuvant diagnosis. However, the processes of fixing or embedding the specimens for light microscopy often destroys the fine structure of organelles in the cytoplasm, making it difficult to observe mitochondria clearly.

Acinic cell adenocarcinoma may be differentiated from oncocytic carcinoma by its amphophilic or basophilic cytoplasmic granules, negative staining for mithochondrial antigens and the presence of a connective tissue capsule. Cytologic examination of Warthin’s tumor shows oncocytes together with lymphocytes, amorphous material and cystic fluid. However, the possibility of oncocytoma should be considered when the smear contains only oncocytes (35).

PTAH staining has been successfully used to identify oncocytes; Brandwein and Huvos (36) particularly recommended the use of prolonged (48 h) PTAH staining, which results in positive, dark-blue cytoplasmic granules. It has also been reported that immunohistochemistry using an anti-mitochondrial antibody is a highly sensitive and specific method for identifying mitochondria using light microscopy (37).

Surgical excision is the most widely accepted method of treatment for OC (15), and the majority of the cases described in the literature have included neck dissection. Goode and Corio (38) reported that patients with tumors <2 cm in diameter appeared to have a better prognosis than those that were larger. Adjuvant radiotherapy has been used for the treatment of oncocytic carcinoma, but its true contribution has not yet been elucidated. OC has a potential risk of distant metastasis, and lung, liver and brain metastases have been reported (32). The long-term survival of patients with OC is poor due to distant disease, and long-term follow-up is necessary after therapy (2). In the current study, the patient not only had OC but also thymoma, which is exceedingly rare and may represent the first documented case in the literature.

Acknowledgements

The authors thank Medjaden Bioscience Limited for assisting in the preparation of this manuscript.

References

1 

Ellis GL, Auclair PL, Gnepp DR and Goode PK: Other malignant epithelial neoplasms. Surgical Pathology of the Salivary Glands. Ellis GL, Auclair PL and Gnepp DR: Philadelphia: W. Saunders; pp. 455–488. 1991

2 

Ellis GL and Auclair PL: Tumors of the salivary glands. Atlas of Tumor Pathology: Third Series, Fascicle 17. Armed Forces Institute of Pathology; Washington, DC: pp. 318–324. 1996

3 

Bauer WH and Bauer JD: Classification of glandular tumors of salivary glands; study of one-hundred forty-three cases. AMA Arch Pathol. 55:328–346. 1953.PubMed/NCBI

4 

Guclu E, Oghan F, Ozturk O, Alper M and Egeli E: A rare malignancy of the parotid gland: oncocytic carcinoma. Eur Arch Otorhinolaryngol. 262:567–569. 2005. View Article : Google Scholar

5 

Mizutari K, Naganishi H and Tanaka Y: Oncocytic carcinoma in the submandibular gland: report of a case based on anti-mitochondrial immunohistochemical observations. Auris Nasus Larynx. 32:305–308. 2005. View Article : Google Scholar : PubMed/NCBI

6 

Kimura M, Furuta T, Hashimoto S, Takano T and Nagao K: Oncocytic carcinoma of the parotid gland. A case report. Acta Cytol. 47:1099–1102. 2003. View Article : Google Scholar : PubMed/NCBI

7 

Wischerath H, Brehmer D, Hesse G and Laubert A: Oncocytic adenocarcinoma of the submandibular gland. HNO. 50:565–569. 2002.(In German). View Article : Google Scholar : PubMed/NCBI

8 

Lombardi D, Piccioni M, Farina D, Morassi ML and Nicolai P: Oncocytic carcinoma of the maxillary sinus: a rare neoplasm. Eur Arch Otorhinolaryngol. 263:528–531. 2006. View Article : Google Scholar : PubMed/NCBI

9 

Sugiyama T, Nakagawa T, Narita M, Nakamura S, Inui M and Tagawa T: Pedunculated oncocytic carcinoma in buccal mucosa: immunohistochemical and ultrastructural studies. Oral Dis. 12:324–328. 2006. View Article : Google Scholar : PubMed/NCBI

10 

Ardekian L, Manor R, Peled M and Laufer D: Malignant oncocytoma of the parotid gland: case report and analysis of the literature. Oral Maxillofac Surg. 57:325–328. 1999. View Article : Google Scholar

11 

Cinar U, Vural C, Basak T and Turgut S: Oncocytic carcinoma of the parotid gland: report of a new case. Ear Nose Throat J. 82:699–701. 2003.PubMed/NCBI

12 

Muramatsu T, Hashimoto S, Lee MW, Chung CK, Matsuzaki K, Inoue T, Noma H and Shimono M: Oncocytic carcinoma arising in submandibular gland with immunohistochemical observations and review of the literature. Oral Oncol. 39:199–203. 2003. View Article : Google Scholar : PubMed/NCBI

13 

Ozawa H, Fujii M, Matsunaga T, Masuda K, Hirose S and Taiji H: Oncocytic carcinoma of the parotid gland. J Otolaryngol. 35:189–192. 2006.PubMed/NCBI

14 

Nakada M, Nishizaki K, Akagi H, Masuda Y and Yoshino T: Oncocytic carcinoma of the submandibular gland: a case report and literature review. J Oral Pathol Med. 27:225–228. 1998. View Article : Google Scholar : PubMed/NCBI

15 

Corbridge RJ, Gallimore AP, Dalton CG and O’Flynn PE: Oncocytomas of the upper jaw. Head Neck. 18:374–380. 1996. View Article : Google Scholar : PubMed/NCBI

16 

Yang GZ, Gao LX and Ding HY: Salivary gland carcinoma with eosinophilia neuroendocrine differentiation. Chin J Pathol. 33:582–583. 2004.

17 

Wang SY, Lou JL and DU XH: Oncocytic Carcinoma of Parotid Gland: A Case Report. J Oncol. 14:689–691. 2008.

18 

Tian XQ and Wang WZ: Oncocytic carcinoma of Salivary gland, a case report. Zhong liu yan jiu yu lin chuang. 14:252–253. 2002.

19 

Dong DX, Shi PX and Li YL: Salivary Gland Cancer: A case report. J Diagn Pathol. 8:183–184. 2001.

20 

Zhou CX, Shi DY, Ma DQ, Zhang JG, Yu GY and Gao Y: Primary oncocytic carcinoma of the salivary glands: A clinicopathologic and immunohistochemical study of 12 cases. Oral Oncol. 46:773–778. 2010. View Article : Google Scholar : PubMed/NCBI

21 

Lee WY and Chang SL: Fine needle aspiration cytology of oncocytic carcinoma of the submandibular gland with pre-existing oncocytoma: a case report. J Cytopathology. 21:339–341. 2010. View Article : Google Scholar

22 

Gallego L, García-Consuegra L, Fuente E, Calvo N and Junquera L: Oncocytic carcinoma of the parotid gland with late cervical lymph node metastases: a case report. J Med Case Rep. 5:112011. View Article : Google Scholar : PubMed/NCBI

23 

Fornasiero A, Daniele O, Ghiotto C, et al: Chemotherapy of invasive thymoma. J Clin Oncol. 8:1419–1423. 1990.PubMed/NCBI

24 

Detterbeck FC and Parsons AM: Thymic tumors. Ann Thorac Surg. 77:1860–1869. 2004. View Article : Google Scholar : PubMed/NCBI

25 

Marx A, Harris NL, Strobel Ph, et al: Thymomas. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. Travis DW, Brambilla E, Muller-Hermelink HK and Harris CC: IARC Press; Lyon: pp. 152–157. 2004

26 

Hamperl H: Beitrage zur normalen und pathologischen histology menschlicher speicheldrusen. Z Microanat Forsch. 27:1–55. 1931.(In German).

27 

Alberty J, August C and Stoll W: Oncocytic neoplasms of the parotid gland. Differential diagnosis, clinical course and review of the literature. HNO. 49:109–117. 2001.(In German). View Article : Google Scholar : PubMed/NCBI

28 

Dardick I, Birek C, Lingen MW and Rowe PE: Differentiation and the cytomorphology of salivary gland tumors with specific reference to oncocytic metaplasia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 88:691–701. 1999. View Article : Google Scholar

29 

Linnane AW1, Marzuki S, Ozawa T and Tanaka M: Mitochondrial DNA mutations as an important contributor to ageing and degenerative diseases. Lancet. 25:642–645. 1989. View Article : Google Scholar

30 

Sciubba JJ and Shimono M: Oncocytic carcinoma. World Health Organization Classification of Tumors: Pathology and Genetics: Head and Neck Tumours. Barnes L, Eveson JW, Reichart D and Sidransky D: IARC Press; Lyon: pp. 2352005

31 

Sugimoto T, Wakizono S, Uemura T, Tsuneyoshi M and Enjoji M: Malignant oncocytoma of the parotid gland: a case report with an immunohistochemical and ultrastructural study. J Laryngol Otol. 107:69–74. 1993. View Article : Google Scholar : PubMed/NCBI

32 

Gray SR, Cornog JL Jr and Seo IS: Oncocytic neoplasms of salivary glands: a report of fifteen cases including two malignant oncocytomas. Cancer. 38:1306–1317. 1976. View Article : Google Scholar : PubMed/NCBI

33 

Ito K, Tsukuda M, Kawabe R, et al: Benign and malignant oncocytoma of the salivary glands with an immunohistochemical evaluation of Ki-67. ORL J Otorhinolaryngol Relat Spec. 62:338–341. 2000. View Article : Google Scholar : PubMed/NCBI

34 

Zhou CX and Gao Y: Oncocytoma of the salivary glands: a clinicopathologic and immunohistochemical study. Oral Oncol. 45:e232–e238. 2009. View Article : Google Scholar : PubMed/NCBI

35 

Yang T and Guo LN: Oncocytic carcinoma. Diagnostic Pathology: First Series. Liu TH: People’s Medical Publishing Press; Beijing: pp. 617–618. 2013

36 

Brandwein MS and Huvos AG: Oncocytic tumors of major salivary glands: a study of 68 cases with follow-up of 44 patients. Am J Surg Pathol. 15:514–528. 1991. View Article : Google Scholar : PubMed/NCBI

37 

Shintaku M and Honda T: Identification of oncocytic lesions of salivary glands by anti-mitochondrial immunohistochemistry. Histopathology. 31:408–411. 1997. View Article : Google Scholar

38 

Goode RK and Corio RL: Oncocytic adenocarcinoma of salivary glands. Oral Surg Oral Med Oral Pathol. 65:61–66. 1988. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

February-2015
Volume 9 Issue 2

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Cao Y, Zhu M, Mao R, Cao R, Yu G and Niu A: Oncocytic carcinoma of the salivary gland with thymoma: A case report and review of the literature. Oncol Lett 9: 681-684, 2015
APA
Cao, Y., Zhu, M., Mao, R., Cao, R., Yu, G., & Niu, A. (2015). Oncocytic carcinoma of the salivary gland with thymoma: A case report and review of the literature. Oncology Letters, 9, 681-684. https://doi.org/10.3892/ol.2014.2707
MLA
Cao, Y., Zhu, M., Mao, R., Cao, R., Yu, G., Niu, A."Oncocytic carcinoma of the salivary gland with thymoma: A case report and review of the literature". Oncology Letters 9.2 (2015): 681-684.
Chicago
Cao, Y., Zhu, M., Mao, R., Cao, R., Yu, G., Niu, A."Oncocytic carcinoma of the salivary gland with thymoma: A case report and review of the literature". Oncology Letters 9, no. 2 (2015): 681-684. https://doi.org/10.3892/ol.2014.2707